[Interleukin-6 and epithelial tumours: new convincing arguments in favour of the use of IL-6 targeted therapies].
Gougelet
Angélique
A
Mansuy
Adeline
A
Blay
Jean-Yves
JY
D017209:Apoptosis; D001943:Breast Neoplasms / Q000473:pathology / Q000503:physiopathology; D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000503:physiopathology; D002455:Cell Division; D018450:Disease Progression; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood / Q000502:physiology*; D007680:Kidney Neoplasms / Q000473:pathology / Q000503:physiopathology; D009375:Neoplasms, Glandular and Epithelial / Q000473:pathology / Q000503:physiopathology*
D015850:Interleukin-6